Markets
Stocks
Mutual Funds & ETF's
Sectors
Tools
Overview
Market News
Currencies
International
Search InvestCenter
Recent Quotes
View Full List
My Watchlist
Create Watchlist
Top Indices
DJI
Nasdaq Composite
SPX
My Portfolio
Arrowhead Pharma
(NQ:
ARWR
)
28.60
-0.10 (-0.35%)
Streaming Delayed Price
Updated: 4:00 PM EDT, Mar 28, 2024
Add to My Watchlist
Quote
Overview
Detailed Quote
Charting
Historical Prices
News
All News
News Headlines
Press Releases
Research
Quarterly Reports
Insider Filings
Other Filings
Price and Volume
Detailed Quote
Volume
589,030
Open
28.75
Bid (Size)
28.20 (2)
Ask (Size)
28.60 (26)
Prev. Close
28.70
Today's Range
28.04 - 29.08
52wk Range
20.67 - 42.48
Shares Outstanding
105,736,200
Dividend Yield
N/A
Intraday
1 Week
1 Month
3 Month
1 Year
3 Year
5 Year
Top News
More News
Arrowhead Pharmaceuticals Initiates Expanded Access Program for Plozasiran and Announces Upcoming Presentation of Clinical Data
March 25, 2024
From
Arrowhead Pharmaceuticals, Inc.
Via
Business Wire
7 Biotech Stocks to Buy as Sector Rotation Ramps Up
March 13, 2024
With digital innovation possibly getting overextended, now’s the time to consider biotech stocks for an incoming rotation.
Via
InvestorPlace
Performance
YTD
-7.77%
-7.77%
1 Month
-8.23%
-8.23%
3 Month
-7.74%
-7.74%
6 Month
+6.20%
+6.20%
1 Year
+15.60%
+15.60%
More News
Read More
The 3 Most Undervalued Russell 2000 Stocks to Buy in March 2024
March 11, 2024
Via
InvestorPlace
EQT, Genie Energy And Other Big Stocks Moving Lower On Monday
March 11, 2024
Via
Benzinga
Topics
Stocks
Exposures
US Equities
Cracking The Code: Understanding Analyst Reviews For Arrowhead Pharma
February 07, 2024
Via
Benzinga
Recap: Arrowhead Pharma Q1 Earnings
February 06, 2024
Via
Benzinga
Earnings Scheduled For February 6, 2024
February 06, 2024
Via
Benzinga
Arrowhead Pharmaceuticals Initiates Phase 1/2a Study of ARO-DM1 for Treatment of Type 1 Myotonic Dystrophy
March 08, 2024
From
Arrowhead Pharmaceuticals, Inc.
Via
Business Wire
Arrowhead Pharmaceuticals to Participate in Upcoming March 2024 Conferences
March 04, 2024
From
Arrowhead Pharmaceuticals, Inc.
Via
Business Wire
Cooper Companies Reports Upbeat Results, Joins Dell, NetApp, Tidewater And Other Big Stocks Moving Higher On Friday
March 01, 2024
Via
Benzinga
Topics
Stocks
Exposures
US Equities
4 Analysts Assess Arrowhead Pharma: What You Need To Know
January 02, 2024
Via
Benzinga
7 Oversold Russell 2000 Stocks to Add to Your February Buy List
February 25, 2024
Via
InvestorPlace
Weight-Loss Drugs Have One Big Problem. These Drugmakers Are Taking It On.
February 23, 2024
Via
Investor's Business Daily
7 Biotech Stocks Fighting America’s Deadliest Diseases
February 08, 2024
Via
InvestorPlace
12 Health Care Stocks Moving In Tuesday's After-Market Session
February 06, 2024
Via
Benzinga
Arrowhead Pharmaceuticals Reports Fiscal 2024 First Quarter Results
February 06, 2024
From
Arrowhead Pharmaceuticals, Inc.
Via
Business Wire
Arrowhead Pharmaceuticals to Webcast Fiscal 2024 First Quarter Results
January 22, 2024
From
Arrowhead Pharmaceuticals, Inc.
Via
Business Wire
Arrowhead Pharmaceuticals Closes Underwritten Offering with Gross Proceeds of $450.0 Million
January 05, 2024
From
Arrowhead Pharmaceuticals, Inc.
Via
Business Wire
Eli Lilly, Crispr, Biogen Lead Pharma And Biotech Stocks To Great Expectations In 2024
January 05, 2024
Via
Investor's Business Daily
Lamb Weston Posts Upbeat Results, Joins Omega Therapeutics, Allstate And Other Big Stocks Moving Higher On Thursday
January 04, 2024
Via
Benzinga
Topics
Stocks
Exposures
US Equities
Why SoFi Technologies Shares Are Trading Lower By Around 13%? Here Are Other Stocks Moving In Wednesday's Mid-Day Session
January 03, 2024
Via
Benzinga
Why Arrowhead Pharmaceuticals Shares Are Moving
January 03, 2024
Via
Benzinga
TDCX Receives Preliminary Non-binding Proposal Letter, Joins Pure Storage, Dyne Therapeutics And Other Big Stocks Moving Higher On Wednesday
January 03, 2024
Via
Benzinga
Topics
Stocks
Exposures
US Equities
Arrowhead Pharmaceuticals Announces Pricing of $450.0 Million Underwritten Offering of Common Stock
January 03, 2024
From
Arrowhead Pharmaceuticals, Inc.
Via
Business Wire
Arrowhead Pharmaceuticals Reports Inducement Grants under NASDAQ Listing Rule 5635(c)(4)
December 29, 2023
From
Arrowhead Pharmaceuticals, Inc.
Via
Business Wire
Data & News supplied by
www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy
and
Terms and Conditions
.